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ABSTRACT The objective of this article is to compare demographic characteristics, risk
behaviors, and service utilization among injection drug users (IDUs) recruited from two
separate studies in San Francisco in 2005, one which used targeted sampling (TS) and
the other which used respondent-driven sampling (RDS). IDUs were recruited using TS
(n=651) and RDS (n=534) and participated in quantitative interviews that included
demographic characteristics, risk behaviors, and service utilization. Prevalence estimates
and 95% confidence intervals (CIs) were calculated to assess whether there were
differences in these variables by sampling method. There was overlap in 95% CIs for all
demographic variables except African American race (TS: 45%, 53%; RDS: 29%, 44%).
Maps showed that the proportion of IDUs distributed across zip codes were similar for
the TSand RDS sample, with the exception of a single zip code that was more represented
in the TS sample. This zip code includes an isolated, predominantly African American
neighborhood where only the TS study had a field site. Risk behavior estimates were
similar for both TS and RDS samples, although self-reported hepatitis C infection was
lower in the RDS sample. In terms of service utilization, more IDUs in the RDS sample
reported no recent use of drug treatment and syringe exchange program services. Our
study suggests that perhaps a hybrid sampling plan is best suited for recruiting IDUs in
San Francisco, whereby the more intensive ethnographic and secondary analysis
components of TS would aid in the planning of seed placement and field locations for
RDS.
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INTRODUCTION
In order to establish the prevalence of a disease or health-related behavior in a
population, the gold standard is to develop a probability-based representative
sample. However, with populations deﬁned by illicit or stigmatized behavior, a
probability-based sampling frame is not usually feasible. Instead, researchers make
inferences based upon a portion of the target population gathered using non-
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839probability-based methods. The validity of these studies depends upon how
representative the sample is of the target population.
1,2 To optimize representative-
ness of samples, it is important to plan and execute recruitment of study participants
who proportionately have the same characteristics as the target population.
Sampling of drug users has been hampered because people who use illicit substances
are involved in stigmatized behaviors that make a substantial proportion of them
unwilling to identify themselves as being drug users.
3–6
Studies of injection drug users (IDUs) in the mid-20th century relied on
institutional settings such as hospitals, jails, and drug treatment centers as sampling
frames. These sampling frames had inherent selection biases because of differences in
prevalence of disease or risk behaviors among IDUs in or entering institutional
settings compared to IDUs in community-based settings.
7,8 As the HIV/AIDS
epidemic emerged in the United States in the mid-1980s, IDUs were identiﬁed as a
high-risk group that needed to be studied outside of institutional settings. Two
sampling methods were developed and utilized: targeted sampling (TS) and snowball
sampling, which later was modiﬁed to develop respondent-driven sampling (RDS).
In 1986, Watters and Biernacki
9 developed TS methods in San Francisco to
recruit IDUs directly from communities. This method involves using secondary
analysis of existing data (from drug treatment programs, hospitals, jails, etc.) and
primary collection of ethnographic data to ﬁrst establish characteristics of the target
population. Then targeted enrollment plans (quotas) for each geographic area and
demographic characteristic are established, and recruitment is conducted through
the use of community health outreach workers.
9 TS is an iterative process designed
to assess the characteristics of the sample at several points so that sampling can be
adjusted in service of obtaining a ﬁnal sample similar to that of the hypothesized
target population. It quickly became the most common recruitment method to study
IDUs in the United States, including its use in the 23-city, National Institute on Drug
Abuse (NIDA)-funded Cooperative Agreement study in the 1990s.
10,11 While TS has
been a successful sampling method of IDUs, there is no formal way to assess whether
the samples are representative. As such, it is not feasible to calculate valid prevalence
estimates. In more recent years, researchers have enhanced TS by estimating the density
of drug users in the target areas and using proportional sampling quotas.
12,13 These
enhancements, however, have been shown to have signiﬁcant selection biases.
4,8
Snowball sampling (also called chain referral) was developed in the 1960s by
Goodman
14 and is a logistically simple way of recruiting a convenience sample when
the target population is hidden, and there is reason to believe that there are large
social networks within the target population who would be willing to recruit
members into a study. It involves starting with a few members of the target
population and then giving them an incentive to bring in their acquaintances who
qualify for the study. Those new recruits are also given incentives to bring in their
acquaintances, and so on. This method of sampling was used to recruit IDUs and
heroin users in the 1980s,
15 including in the NIDA-funded 29-city National AIDS
Demonstration Research project from 1987 to 1992.
16,17 An important tenet of
snowball sampling is that initial recruits (also called “seeds”) be selected at random
from the target population.
14 However, because selecting the initial recruits at
random is not possible with IDUs, the studies using snowball sampling to recruit
IDUs in the 1980s and early 1990s were essentially considered convenience samples.
However, in 1997, Heckathorn
18 used mathematical modeling and data simulation
to demonstrate that it is possible to generate population-based estimates by tracking
the social networks of participants who refer each other to the study, given certain
KRAL ET AL. 840assumptions. He called this reﬁned snowball sampling method RDS. By keeping track
of who is referring whom, it is possible to identify a sequence of recruiter–recruit chains
called “recruitment waves.” If these chains are sufﬁciently large, the composition of the
sample (i.e., with respect to its demographic and behavioral characteristics) gradually
stabilizes. At this point, the sample is said to have reached “equilibrium,” meaning that
subsequent recruitment does not greatly alter the makeup of the sample and that
sufﬁcient data are collected to estimate and adjust for recruitment biases. Throughout
the survey,the recruiter–recruitchainsneedtobe carefullymonitoredandthe sizeof the
social network of each participant needs to be recorded. Using these network-size data
and the characteristics of recruits and recruiters, statistical adjustments are made to the
survey results to account for different probabilities of inclusion and the cluster effects
introduced bythe networked nature of the sample.
19 In the 2000s, RDS become a very
common method of recruiting IDUs in the United States, including in the Centers for
Disease Control and Prevention (CDC)-funded 25-city National HIV Behavioral
Surveillance (NHBS) study, and internationally.
20–28
Currently, TS and RDS are the two most common methods used to sample IDUs
in the United States. Robinson et al.
20 conducted a study that provided information
comparing logistics and costs of using TS and RDS to recruit IDUs in Detroit,
Houston, and New Orleans. Due to small sample size, they were not able to conduct
a thorough analysis comparing the characteristics of the samples by method. This
article is among the ﬁrst to compare demographic and behavioral characteristics of
IDUs from two separate studies of IDUs, one which used TS (n=651) and the other
which used RDS (n=534).
METHODS
We conducted two separate studies of IDUs in San Francisco in 2005, one using TS
and the other using RDS. Below, we describe the methods for each study.
Targeted Sampling
The TS study was the 37th semiannual cross-section of the Urban Health Study
(UHS), a study of IDUs in San Francisco. Watters and Biernacki,
9 the developers of
TS, ﬁrst implemented the method in the ﬁrst UHS cross-section in 1986. The
procedures and results from this study have been published extensively over the past
two decades.
29–31 Brieﬂy, the ﬁve steps involved in developing and reﬁning the TS
plan are as follows: (1) Collect indicator data from sources including drug treatment
admissions data, IDU HIV/AIDS case data from the San Francisco Department of
Public Health (SFDPH), data from Citywide HIV testing sites, and narcotics arrest
data from the San Francisco police departments. (2) Collect ethnographic data
through block-by-block “walk-throughs,” which were conducted at different times
of day and night. Ethnographic data collection also included discussions with key
informants regarding their observations on the prevalence and type of drug use in
various communities. (3) Develop TS plan by estimating the size and demographic
characteristics of the IDU population in each area and set recruitment targets. (4)
Conduct outreach to recruit IDUs to community ﬁeld sites in the neighborhoods
with the highest concentration of IDUs per secondary data (marked by stars in
Fig. 1b). (5) Reﬁne and revise targeted sample after monthly assessments of how
well the recruitment targets were met.
Eligibility criteria included the following: (1) reported injecting illicit drugs
within the past 30 days, (2) had visible sign of injection (“tracks”), (3) were at least
RDS VS. TARGETED SAMPLING OF IDUS 84118 years of age at the time of interview, and (4) were able to speak English or Spanish.
Participants from previous serial cross-sections did not receive any special recruitment
contact, but they were automatically eligible for future cross-sections (6 months apart),
even if they had switched to noninjecting methods or had quit using drugs. Participants
were assigned a unique ID code, and we checked their identiﬁcation by asking ﬁve
questions: sex, birth year, age, race/ethnicity, state of birth, and ﬁrst two letters of
mother's maiden name. This helped to determine which observations were duplicates.
For this analysis, we only included active IDUs who reported injecting drugs in the
previous 30 days.
After providing informed consent to this anonymous study, participants were
interviewed in person by a trained interviewer in a private space using a structured
questionnaire on a computer-assisted programmed interview (CAPI) using QDS
software (QDS; NOVA Research Company, Bethesda, MD). They were paid $15 for
contributing to the study. Questions covered demographic information, injecting
and sexual risk behaviors, and utilization of health care, drug treatment, and HIV
prevention programs. The questions pertained to the 6-month period preceding the
interview date. Blood specimens were drawn following the interview to assess HIV
status using enzyme immunoassay and Western blot assay, following standard
laboratory methods. Participants were asked to return for HIV serology results in
2 weeks. They were offered HIV counseling, provided with referrals to medical and
social services, and paid $15. Study protocols were approved by the University of
California, San Francisco (UCSF) Committee on Human Research.
Respondent-Driven Sampling
SFDPH conducted a cross-sectional behavioral surveillance survey using RDS among
IDU in San Francisco in 2005, as part of the CDC NHBS study. A standard protocol
developed in collaboration with CDC and researchers from 24 other US metropolitan
FIGURE 1. Distribution of study recruits by zip code. a RDS. b Targeted sampling.
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32 Below is a brief description of the speciﬁcs to RDS as used
in this study.
After a review of AIDS case surveillance data and existing secondary data, the
SFDPH team drew up a preliminary list of diverse characteristics (i.e., race/ethnicity,
gender, age, neighborhood, and injection drug of choice) that were desired in the
initial recruitment of seed subjects. Enlisting the help of several key informants,
active IDUs were identiﬁed and approached who met the initial criteria and who
also had relatively large network sizes (i.e., IDU who had social ties with several
other IDU and were well known in the IDU community). Eight seeds were selected
during the ﬁrst month of the study, and an additional eight seeds were recruited
during data collection to form a group of seeds diverse in such demographic
characteristics as age, race, and sex, as well as drug of choice. The seeds were given
$40 in cash as an incentive for participating in the study and were given three
recruitment coupons when they completed the survey. Each coupon listed the
objectives of the project, contact information and working hours of the study site,
the amount of the incentive for participation of prospective recruits, and a unique
tracking code. The seeds were trained in how to use each coupon to recruit an IDU
from their network of peers to participate in the survey. They were told that they
would receive an additional $10 for each recruit who brought in his or her coupon
and completed the survey. The recruited IDU would go through the same procedures
as the initial seeds, including eligibility screening, interview, delivery of three new
coupons, and training in how to recruit other IDU. Unique tracking codes on
coupons were used to document who recruited whom and to facilitate payment of
the monetary incentives. A customized version of the database program, Respondent
Driven Sampling Coupon Manager (RDSCM), was used to collect recruitment
data.
33
Eligibility criteria included the following: (1) injection drug use within the past
12 months; (2) visible sign of injection (e.g., track marks, scars, needle-sized scabs)
or could correctly describe injection practices; (3) were at least 18 years of age at the
time of interview; (4) were able to speak English; and (5) were residents of San
Francisco. To be eligible for the survey, participants were required to present a
recruitment coupon to SFDPH staff, which then explained study procedures and
obtained informed consent. After screening participants for eligibility, explaining the
study's procedures, and obtaining consent, interviewers conducted a face-to-face
interview with each participant using a computerized questionnaire on a handheld
device. The questionnaire was developed using the same software as for the TS study
above (QDS). Interviews took place in private rooms at SFDPH (marked by a star in
Fig. 1a).
The survey instrument contained two parts. The ﬁrst part sought speciﬁc
information about the social networks of the participants required for RDS-speciﬁc
data analysis. Such information included the size of the participant's social network
(e.g., the number of other injectors he or she had been acquainted with during the
previous 6 months), rough estimations of the sex and race/ethnicity composition of
the members of their social networks, and the relationship of each recruit to his or
her recruiter (e.g., friend, sex partner). To determine the size of the participants'
networks, we asked all participants the questions, “How many people do you know
personally who inject?” and “Of these injectors, how many have you seen at least
once in the last 6 months?” The second part of the survey instrument dealt with the
participants' demographic characteristics, drug use, sexual risk behaviors, and access
to types of drug treatment and HIV prevention programs (e.g., methadone treatment
RDS VS. TARGETED SAMPLING OF IDUS 843programs, syringe exchange programs [SEPs]). There was no HIV testing or
counseling in the RDS study.
Participation was anonymous. This survey was part of the larger NHBS system
and was classiﬁed as a nonresearch survey by the CDC Institutional Review Board
and the UCSF Committee on Human Research.
Statistical Analysis
For the purpose of making comparisons between RDS and TS, we focused our
analysis on key indicators in three basic domains: (1) sociodemographic character-
istics, (2) drug of choice, and (3) access to and use of HIV prevention and treatment
programs including drug and alcohol treatment programs, and received sterile
needles for injection.
To analyze the RDS-generated data, we used Respondent-Driven Sampling
Analysis Tool (RDSAT v. 6.0). We calculated population-based proportions and
95% conﬁdence intervals (CIs) for selected key variables listed above. RDSAT
adjusts for each individual's network size and characteristics in relation to the other
recruits. For TS data, we computed point prevalence estimates and 95% CIs for
select variables using Stata version 9 (StataCorp LP, College Station, TX). To
determine whether there were statistically signiﬁcant differences, we assessed
whether there was an overlap in 95% CI between the same variables in the two
studies.
RESULTS
IDU recruitment using TS was completed in 16 weeks. Because of the informal way
that advertising TS studies is conducted, there is no way of knowing how many
IDUs were informed about the study and decided not to participate. A total of 651
IDUs participated in the study and are included in the analyses. IDU recruitment
using RDS lasted 32 weeks, and the 16 seeds selected for the study generated 27
waves of recruitment. A total of 1,435 coupons were distributed through these
recruits, and 630 IDUs bearing recruitment coupons presented themselves for the
study for a 44% coupon return rate. Of these recruits, 571 (91%) were deemed
eligible and were enrolled into the study. In total, 534 subjects who completed valid
interviews were included in the current analysis. There was some overlap in
participation of both studies, with 24.7% (adjusted; 22% crude) of IDUs in the RDS
study reporting that they had participated in the TS study in the past year.
We compared demographic characteristics, risk factors, and utilization of
treatment and prevention programs in the TS and RDS studies (Table 1). In both
samples, the majority were over 45 years old and male. The samples were similar
demographically, with the exception of race/ethnicity. TS estimated a higher
proportion of African Americans than RDS (49.3% vs. 35.7%), and the 95% CIs
did not overlap. More TS participants than RDS participants reported having tested
positive for hepatitis C virus (HCV) (79.7% vs. 55.9%). RDS study participants
were less likely to report using methadone maintenance and methadone detoxiﬁcation
services (6% and 5%, respectively), as compared with participants in the TS study
(19.2% and 14.1%, respectively). Finally, less RDS participants than TS participants
reported obtaining syringes from SEPs (81% vs. 95%), while a larger proportion of
RDS participants reported purchasing syringes at pharmacies (17.0% vs. 9.2%) in the
past 12 months.
KRAL ET AL. 844TABLE 1 Comparison of IDUs recruited using targeted sampling and RDS, San Francisco, 2005
Variable
RDS (NHBS) (n = 534) TS (UHS) (n=651)
Crude (%) Adjusted (%)
Adjusted,
95% CI Crude (%)
Unadjusted
95% CI
Age (years)
18–20 0.0 0.0 – 0.2 0.0–99.0
21–25 2.1 1.1 0.3–1.9 2.2 1.2–3.7
26–30 1.9 1.6 0.6–2.5 4.9 3.4–7.0
31–35 6.5 7.9 4.4–11.9 6.6 4.9–8.9
36–40 16.1 17.5 13.6–22.4 10.8 8.5–13.5
41–45 19.1 19.7 14.1–26.7 18.7 15.9–22.0
46–50 22.4 19.8 15.2–24.9 24.7 21.5–28.3
≥51 31.9 32.2 26.1–38.4 32.0 28.4–35.7
Race/ethnicity
Native American 2.5 5.8 2.2–9.5 2.5 1.5–4.0
Asian 0.4 0.6 0.0–1.9 0.2 0.0–1.0
African American 32.6 35.7 29.3–44.0 49.3 45.0–53.0
Native Hawaiian/Paciﬁc Islander 0.4 0.5 0.0–1.2 0.3 0.0–1.2
Non-Hispanic White 40.8 35.3 28.9–41.8 35.8 3.2–39.6
Hispanic 10.5 12.9 6.7–18.6 7.3 5.4–9.6
Other 1.9 1.5 0.5–3.3 4.8 3.3–6.8
Mixed 11.1 7.6 5.4–10.2 NA NA
Gender
Male 73.6 71.3 64.4–78.5 71.3 67.6–74.7
Female 24.5 26.1 19.4–33.1 25.2 21.9–28.74
Transgender 1.9 2.6 0.7–4.4 3.5 2.3–5.3
Ever tested for HIV
No 2.7 2.6 1.3–4.0 1.0 0.4–2.1
Yes 97.3 97.4 95.9–98.8 99.0 98.0–99.6
Negative 79.9 79.5 74.4–84.7 86.5 83.6–89.0
Self-reported HIV status
Positive 11.9 13.0 8.7–17.6 9.7 7.6–12.3
Did not receive results 5.2 4.3 2.4–6.6 2.9 1.8–4.6
Indeterminate 0.2 0.7 0.0–1.6 0 0
Never tested 2.7 2.6 1.2–4.1 1.0 0.4–2.1
Ever tested positive for HCV 59.5 55.9 49.8–63.1 69.7 65.9–73.1
Ever participated in alcohol/drug
treatment programs
68.6 65.7 60.3–71.9 74.8 71.3 -78.1
Programs used in the past 12 months
Methadone maintenance 8.0 5.8 3.7–8.2 19.2 16.3–22.5
Methadone detoxiﬁcation 6.5 5.4 3.5–7.6 14.1 11.6–17.1
In-patient drug treatment 7.8 5.1 3.2–7.1 3.7 2.4–5.5
Residential drug treatment 5.6 6.7 3.7–9.8 9.2 7.1–11.8
Outpatient drug treatment 7.2 5.0 3.5–7.7 4.3 2.9–6.2
Alcoholics anonymous 5.9 6.8 4.2–10.5 11.8 9.5–14.6
Narcotics anonymous 5.6 5.3 3.3–8.3 N/A N/A
Purchased syringes at
pharmacy in 12 months
16.8 17.0 11.9–24.1 9.2 7.1–11.8
Obtained syringes via SEP in
the past 12 months
86.8 81.8 76.2–86.7 95.4 93.4–96.8
Numbers in bold are those where 95% CIs did not overlap. NA = not available.
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proportion of recruited IDUs by zip code of where they usually live (Fig. 1a and b).
The geographic distribution of IDUs for each sample shows a similar pattern across
zip codes. One notable exception is that compared to the TS sample, the RDS
sample had a signiﬁcantly lower proportion of participants in zip code 94124, which
is an impoverished, geographically isolated neighborhood consisting largely of
African Americans. Only the TS study had a ﬁeld site located in zip code 94124
(marked by stars in Fig. 1b).
DISCUSSION
Our research shows that TS and RDS both resulted in sizable and diverse samples of
IDUs in San Francisco. IDUs in San Francisco are easily accessible through
community-based street-intercept methods, as demonstrated by the TS study. They
are socially networked and suitable for peer-recruitment sampling, as demonstrated
by the RDS study. We were able to satisfy the RDS methodological requirements,
which means that we were theoretically able to generate representative estimates of
demographic variables and indicators of access to health care of the IDU population.
We found that the TS and RDS studies reached similar samples of IDU in terms
of demographic characteristics, with the exception of African Americans. African
Americans represent a small minority of the population in San Francisco (6.9% in
2007 per the US Census Bureau
39) and are largely concentrated in one neighborhood
in the southeastern part of the city (Bayview/Hunter's Point, zip code 94124), which
in 2005 was isolated from the rest of the city geographically by highway systems and
poor access via public transportation (two bus lines, no streetcar, no subway).
Through the secondary analysis and ethnography components of TS methodology,
this neighborhood was identiﬁed as having a large population of IDUs, and a ﬁeld site
was placed in its midst. While the RDS study attempted to include IDUs from this
neighborhood (three seeds), we hypothesize that the long travel time between the
neighborhood and the RDS data collection site may have limited study participation.
This ﬁnding suggests that when utilizing RDS, it may be wise to implement some of
the steps of TS during the planning stages, which can be used to decide how many and
where to establish data collection sites. This could include collecting secondary
indicator data and conducting a brief ethnography to ﬁgure out where IDUs are
located and what cultural factors may be important to consider in designing the
procedures of the study. The ﬁnding also underscores the importance of including
geographic markers (zip codes or census tracts) on surveys of IDUs to assess
geographic reach.
The two samples differed substantially with respect to the proportion of
participants who had utilized current prevention and care programs in San
Francisco. Fewer RDS participants reported use of drug treatment and SEP,
although SEP use was very high overall. This ﬁnding implies that RDS may be
more effective than TS at reaching IDUs not receiving services. If the use of RDS is
coupled with a proactive system of referral to services, the study can potentially
bring IDU with less access to care into prevention and treatment programs.
The TS sample had a higher proportion of IDU who had reported “ever testing
positive” for HCV, compared to the RDS sample. This ﬁnding might be because the
TS sample included more IDU who had ever been in drug treatment. Those who
have access to care are more likely to be tested for HCV. Another explanation is that
the TS study provided HCV testing for participants from 1998 to 2001, and many in
KRAL ET AL. 846the 2005 TS sample had participated in the earlier cross-sections. HCV prevalence
among IDUs in the TS study during those years was 91%.
34
There are several limitations to this study that need to be considered when
interpreting its results. Although TS and RDS were both very effective in generating
diverse samples, there is no way of knowing whether these samples are
representative of the target population as a whole. TS has several limitations that
should be noted. It requires that IDUs are part of a street culture that is easily
accessed by an outreach worker, relying on the talents of the outreach workers who
are involved in the ethnography and recruitment. For example, younger IDUs may
not be interested in talking with or may not trust an older outreach worker. In RDS,
it is possible to assess whether homophily exists and then corrects for it using
weighting in RDSAT. Another limitation of the study is that the TS sample consisted
of the 37th cross-section of a long-standing study, which may have generated a
different sample than if it had been a ﬁrst-time TS sample. The reputation of the
study in the community may have biased the attributes of those who were willing to
participate. RDS also has several limitations. It cannot access those who are not
socially networked or isolated. For example, in an RDS survey of IDU in Cairo,
Egypt, chains of referrals did not reach women.
35 In a survey of IDU in Tehran, Iran,
the ﬁnal sample lacked women and Afghan IDUs, despite empirical evidence
supporting the existence of such groups.
36 Because RDS does not generally involve
an intensive formative research phase, it is not easy to understand how the study
procedures might bias who decides to participate.
There are also limitations common to both of these studies. Response bias is a
limitation of all surveys, regardless of sampling methods, particularly when studying
populations most at risk for HIV. Measuring the response rate is more challenging in
surveys of IDUs, given that researchers usually are not present when study subjects
are recruiting their peers to ﬁnd out how many potential subjects are approached by
recruiters. There were some differences in eligibility criteria in the two studies, which
may account for some of the observed differences. Speciﬁcally, the RDS study was
limited to English speakers while the TS study also included questionnaires in
Spanish. However, in reality, no study participants in the TS study chose to be
interviewed in Spanish. The time frame for injection criteria was 12 months in the
RDS study and 30 days in the TS study. This may mean that some of the participants
in the RDS study were less likely to be active IDUs. This could have biased the drug
treatment estimates for example, even though drug treatment was less prevalent
in the RDS sample. Finally, the RDS study required San Francisco residency.
From our 20 years of experience conducting research with IDUs in San
Francisco, we feel it is highly unlikely that more than 2% of the TS sample
consisted of IDUs who reside outside of San Francisco. The majority of variables
is self-reported and subject to recall bias and social desirability responses.
However, we expect that these sources of biases would affect both samples
similarly given that populations and type of questions were relatively compara-
ble. Moreover, previous studies of IDUs have found good reliability with respect
to the measures we used to assess the main outcomes in this study.
37,38 And
ﬁnally, because of the different statistical methods needed for analyzing RDS and TS
data, we were not able to combine the datasets and conduct multivariate comparisons
to assess whether the data are signiﬁcantly different. Instead, we relied on assessing
whether the 95% CIs overlapped in the estimates.
In order for quantitative studies of IDUs to be useful for identifying the
prevalence and factors associated with various social and medical outcomes, it is
RDS VS. TARGETED SAMPLING OF IDUS 847important they use a sampling methodology that optimizes generalizability to the
target population. Given that it is not feasible to carry out population-based
randomized sampling of drug users, it is important to choose methods that are
most likely to ﬁt the geographic, social, and political characteristics of the area. It
appears that in San Francisco, both RDS and TS are useful tools for recruiting
IDUs. Our study suggests that perhaps a hybrid model is best suited for San
Francisco, whereby the ethnographic and secondary analysis components of TS
would precede initiation of RDS. This would optimize the beneﬁts of both
methods by assuring that study procedures enable RDS sampling to actualize its
promise of representation.
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